Mortality and neurodevelopmental outcomes of acute bacterial meningitis in children aged <5 years in Pakistan

J Pediatr. 2013 Jul;163(1 Suppl):S86-S91.e1. doi: 10.1016/j.jpeds.2013.03.035.

Abstract

Objective: Significant neurodevelopmental sequelae are known to occur after acute bacterial meningitis (ABM). This study determined the burden of such sequelae in Pakistani children aged <5 years to guide policies for Haemophilus influenzae type b (Hib) and pneumococcal vaccination.

Study design: Cases of ABM were recruited from hospital-based surveillance and assigned to 1 of 3 etiologic groups (Hib, Streptococcus pneumoniae, or unknown etiology). Two age-matched controls were recruited for each case. Six months after enrollment, each case underwent neurologic history and examination, neurodevelopmental evaluation, and neurophysiological hearing test. Controls were assessed in parallel.

Results: Of 188 cases, 64 (34%) died. Mortality among subgroups were 7 (27%), 14 (28%), and 43 (39%) for Hib, Streptococcus pneumoniae, and unknown etiology, respectively. Eighty cases and 160 controls completed the assessments. Sequelae among cases included developmental delay (37%), motor deficit (31%), hearing impairment (18.5%), epilepsy (14%), and vision impairment (14%). Sequelae were higher after pneumococcal meningitis (19, 73%) compared with Hib meningitis (8, 53%). Compared with controls, cases were at significantly higher risk for all sequelae (P < .0001).

Conclusions: ABM causes a substantial long-term burden of poor neurodevelopmental outcomes. Hib and pneumococcal vaccines are very effective interventions to prevent meningitis and its disabling sequelae.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Developmental Disabilities / epidemiology*
  • Female
  • Hearing Tests
  • Humans
  • Infant
  • Male
  • Meningitis, Bacterial / mortality*
  • Meningitis, Pneumococcal / mortality
  • Nervous System Diseases / epidemiology*
  • Pakistan / epidemiology
  • Prognosis
  • Streptococcus pneumoniae*
  • Survival Rate